• Daxor Corporation Appoints Robert J. Michel as Chief Financial Officer pharmafocusasia
    September 29, 2018
    NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointment of Robert J. Mi
PharmaSources Customer Service